Stalevo 175 mg/43.75 mg/200 mg film-coated tablets

Company
Orion Pharma (Ireland) Ltd
Active Ingredient
Dosage Form
Film-coated tablet
Legal Category
B - prescription, may be renewed
Date of revision
01/2022

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/03/260/034 175/43.75 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/035 175/43.75 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/036 175/43.75 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/037 175/43.75 milligram(s) N04BA, N04BA03 Film-coated tablet
EU/1/03/260/038 175/43.75 milligram(s) N04BA, N04BA03 Film-coated tablet
Licence number
EU/1/03/260/034
Strength
175/43.75 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/035
Strength
175/43.75 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/036
Strength
175/43.75 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/037
Strength
175/43.75 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet
Licence number
EU/1/03/260/038
Strength
175/43.75 milligram(s)
ATC Code
N04BA, N04BA03
Dosage Form
Film-coated tablet

Orion Pharma (Ireland) Ltd

c/o Allphar Services Ltd, 4045 Kingswood Road, Citywest Business Park, Co Dublin D24V06K

Website
https://www.orionpharma.ie
Telephone
+35314688482
Email
ie.medicalinformation@orionpharma.com